ENZO BIOCHEM INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Jul 31, 2024	FY2023 12 months to Jul 31, 2023	FY2022 12 months to Jul 31, 2022	FY2021 12 months to Jul 31, 2021	FY2020 12 months to Jul 31, 2020
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Gain on sale of discontinued operations, net of tax
Amortization of intangible assets
Unrealized loss on marketable securities
Foreign exchange (gain) loss
Realized and unrealized loss on marketable securities
Paycheck Protection Program (PPP) loan forgiveness
Impairments of other assets
Change in fair value of convertible debentures
Depreciation and amortization of property, plant and equipment
Share-based compensation charges
Share-based 401(k) employer match expense
Foreign exchange loss (gain)
Provision for inventories
(Gain) loss on lease termination or impairments of other assets
Impairment of right-of-use asset– discontinued operations

Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable – trade
Accrued liabilities, other current liabilities and other liabilities
Total adjustments
Net cash used in operating activities
Cash flows from investing activities:
Purchases of marketable securities
Sales (purchases) of marketable securities
Net proceeds from sale of discontinued operations
Capital expenditures
Sales of marketable securities
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Cash payments for taxes related to net share settlements of equity compensation and awards
Net proceeds from issuance of common stock through ATM
Proceeds from issuance of convertible debentures and warrants
Repayments of convertible debentures
Cost of issuance of convertible debentures and warrants
Proceeds from borrowings under revolving credit agreement
Repayments under revolving credit agreement
Repayments under mortgage agreement and capital leases
Proceeds from exercise of stock options
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents
(Decrease) increase in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash - beginning of year
Cash and cash equivalents and restricted cash - end of year
Composition of cash and cash equivalents and restricted cash is as follows:
Cash and cash equivalents
Total cash and cash equivalents and restricted cash
Restricted cash

Comments